About Index Trending news
Analyze
Pricing
Amgen Inc.

Amgen Inc.

Work at Amgen Inc.? Add yourself to this profile

Amgen Inc.

Amgen engages in the development of human therapeutic products in supportive ofcancer care, inflammation, nephrology and bone diseases.
Edit Profile
More info

Elsewhere

Contributors to this profile

Companies in the same industry

Gamma Medica Gamma Medica Cell Medica Cell Medica NextGxDx, Inc. NextGxDx, Inc. Chromatin, Inc. Chromatin, Inc. Glencoe Software Glencoe Software Apollo Endosurgery Apollo Endosurgery Cure Forward Cure Forward Oxford Nanopore Oxford Nanopore LifeBond LifeBond Genalyte Genalyte

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 8

Portfolio

Acquisitions 4

Apps 1
Add info
10 Apr 2012
KAI Pharmaceuticals
KAI Pharmaceuticals
$315,000,000 From
Amgen Inc.
Amgen Inc.
25 Jan 2011
BioVex
BioVex
$1,000,000,000 From
Amgen Inc.
Amgen Inc.
02 Oct 2008
Avidia
Avidia
$380,000,000 From
Amgen Inc.
Amgen Inc.
06 Jun 2007
Alantos Pharmaceuticals
Alantos Pharmaceuticals
Acquired by
Amgen Inc.
Amgen Inc.

Amgen - Investors - Press Release

amgen